statistiche ricercatore

CLEMENTI, MASSIMO

Distribuzione geografica

Continente	#
NA - Nord America	3.114
EU - Europa	1.840
AS - Asia	1.680
Continente sconosciuto - Info sul continente non disponibili	210
SA - Sud America	179
AF - Africa	38
OC - Oceania	5
Totale	7.066

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	2.938
IT - Italia	1.185
SG - Singapore	708
CN - Cina	412
HK - Hong Kong	255
BR - Brasile	154
VN - Vietnam	129
GB - Regno Unito	118
DE - Germania	93
FR - Francia	92
RU - Federazione Russa	89
FI - Finlandia	81
IE - Irlanda	77
CA - Canada	76
MX - Messico	39
IN - India	37
BD - Bangladesh	29
JP - Giappone	19
NL - Olanda	16
IL - Israele	15
PL - Polonia	15
CR - Costa Rica	12
ES - Italia	12
LT - Lituania	12
IQ - Iraq	11
SE - Svezia	11
TR - Turchia	11
AT - Austria	10
PR - Porto Rico	10
SA - Arabia Saudita	10
SV - El Salvador	10
KE - Kenya	9
AR - Argentina	8
ZA - Sudafrica	8
BE - Belgio	7
GT - Guatemala	7
NG - Nigeria	6
NI - Nicaragua	6
SC - Seychelles	6
TT - Trinidad e Tobago	6
CH - Svizzera	5
AE - Emirati Arabi Uniti	4
AU - Australia	4
CO - Colombia	4
JO - Giordania	4
MD - Moldavia	4
UA - Ucraina	4
VE - Venezuela	4
AZ - Azerbaigian	3
ID - Indonesia	3
KZ - Kazakistan	3
MA - Marocco	3
PK - Pakistan	3
UZ - Uzbekistan	3
BG - Bulgaria	2
CL - Cile	2
CW - ???statistics.table.value.countryCode.CW???	2
DK - Danimarca	2
EC - Ecuador	2
EG - Egitto	2
GE - Georgia	2
GP - Guadalupe	2
KR - Corea	2
LB - Libano	2
PE - Perù	2
PH - Filippine	2
QA - Qatar	2
VC - Saint Vincent e Grenadine	2
AM - Armenia	1
BB - Barbados	1
BH - Bahrain	1
BL - Saint Barthelemy	1
BO - Bolivia	1
BS - Bahamas	1
BY - Bielorussia	1
BZ - Belize	1
CG - Congo	1
CI - Costa d'Avorio	1
CY - Cipro	1
ET - Etiopia	1
GN - Guinea	1
GR - Grecia	1
HN - Honduras	1
IR - Iran	1
JM - Giamaica	1
KG - Kirghizistan	1
MM - Myanmar	1
MY - Malesia	1
NC - Nuova Caledonia	1
NP - Nepal	1
OM - Oman	1
PS - Palestinian Territory	1
PY - Paraguay	1
RS - Serbia	1
SI - Slovenia	1
SK - Slovacchia (Repubblica Slovacca)	1
SY - Repubblica araba siriana	1
UY - Uruguay	1
Totale	6.858

Salva come PNG Salva come JPEG

Città	#
Milan	692
San Jose	601
Council Bluffs	497
Singapore	373
Ashburn	354
Hong Kong	252
Chicago	168
Beijing	156
The Dalles	122
Dallas	106
Boardman	94
Dublin	76
London	75
Los Angeles	73
Rome	73
Helsinki	71
Lauterbourg	71
Naples	46
Santa Clara	46
Ho Chi Minh City	43
New York	41
Hanoi	33
Mexico City	29
Washington	28
Munich	27
Catania	26
Ogden	26
Brooklyn	23
Frankfurt am Main	23
Seattle	20
Orem	18
Tokyo	18
Toronto	18
Varese	17
Atlanta	15
North Bergen	15
San Francisco	15
Warsaw	14
Chennai	13
Como	13
Montreal	12
Shanghai	12
São Paulo	12
San José	11
Guangzhou	10
Nuremberg	10
San Salvador	10
Vancouver	10
Nairobi	9
Boston	8
Denver	8
Houston	8
Phoenix	8
Shenzhen	8
Vienna	8
Amsterdam	7
Brussels	7
Dhaka	7
Pescara	7
Pittsburgh	7
Pune	7
Abuja	6
Ankara	6
Da Nang	6
Guatemala City	6
Hangzhou	6
Johannesburg	6
Managua	6
Minesing	6
New Delhi	6
Poplar	6
San Juan	6
Vilnius	6
Bari	5
Berlin	5
Detroit	5
Düsseldorf	5
Falkenstein	5
Haiphong	5
Magnago	5
Miami	5
Querétaro	5
Rio de Janeiro	5
Salt Lake City	5
Amman	4
Baghdad	4
Belo Horizonte	4
Bodio Lomnago	4
Bologna	4
Brescia	4
Cernusco sul Naviglio	4
Chaguanas	4
Chiswick	4
Greensboro	4
Jeddah	4
Memphis	4
Mumbai	4
Newark	4
Riyadh	4
Sulmona	4
Totale	4.798

Salva come PNG Salva come JPEG

Nome	#
A biologically-validated HCV E1E2 heterodimer structural model	142
A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes	134
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19	133
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study)	126
Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies	122
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases	120
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs	119
Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections	118
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2	117
Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients	117
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes	116
Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies	114
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine	114
Clinical characterization and whole genome sequence-based typing of two cases of endophthalmitis due to Listeria monocytogenes	113
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein	113
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses	112
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools	111
A case of psoriatic arthritis triggered by SARS-CoV-2 infection	110
A human stem cell-derived neurosensory–epithelial circuitry on a chip to model herpes simplex virus reactivation	105
Possible future monoclonal antibody (mAb)-based therapy against arbovirus infections	102
Differential composition of vaginal microbiome, but not of seminal microbiome, is associated with successful intrauterine insemination in couples with idiopathic infertility: A prospective observational study	100
The interferon landscape along the respiratory tract impacts the severity of COVID-19	99
Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens	99
Autoimmune hepatitis and occult HCV infection: A prospective single-centre clinical study	99
Anti-hepatitis C virus E2 (HCV/E2) glycoprotein monoclonal antibodies and neutralization interference	98
Answer to photo quiz: Streptococcus pneumoniae	97
Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia	97
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion?	97
Identification of a novel mutation involved in colistin resistance in Klebsiella pneumoniae through Next-Generation Sequencing (NGS) based approaches	96
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects	94
Combined prophylactic and therapeutic use maximizes hydroxychloroquine anti-SARS-CoV-2 effects in vitro	93
JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes?	93
Viral respiratory pathogens and lung Injury	92
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome	90
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials	89
IFCC interim guidelines on molecular testing of SARS-CoV-2 infection	88
Lower nasopharyngeal viral load during the latest phase of COVID-19 pandemic in a Northern Italy University Hospital	87
Microbiome markers are early predictors of acute GvHD in allogeneic hematopoietic stem cell transplant recipients	87
Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in mice	86
Chimeric antigen receptor (CAR)-redirected T cells: is there a place for them in infectious diseases?	86
Risks of "blind" automated identification systems in medical microbiology	86
Molecular signatures of hepatitis C virus (HCV)-induced type II mixed cryoglobulinemia (MCII)	85
Hepatitis C virus (HCV) infection may elicit neutralizing antibodies targeting epitopes conserved in all viral genotypes	84
Characterization of four major human B-cell epitopes on the surface of HCV E2 glycoprotein by generation of human monoclonal Fab from phage display antibody librariesis	84
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy	83
Enteric microbiome markers as early predictors of clinical outcome in allogeneic hematopoietic stem cell transplant (allo-HSCT): results of a prospective study in adult patients	83
Characterization of two human monoclonal anti-E2/HCV antibodies for potential application in prevention and treatment of HCV infection	82
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects	79
Very high SARS-CoV-2 load at the emergency department presentation strongly predicts the risk of admission to the intensive care unit and death	79
Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with Natalizumab	78
IFCC interim guidelines on biochemical/hematological monitoring of COVID-19 patients	78
Virus-induced preferential antibody gene-usage and its importance in humoral autoimmunity	77
Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle	75
Structural and antigenic definition of hepatitis C virus E2 glycoprotein epitopes targeted by monoclonal antibodies	74
HCV Proteins and Immunoglobulin Variable Gene (IgV) Subfamilies in HCV-Induced Type II Mixed Cryoglobulinemia: A Concurrent Pathogenetic Role	73
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge	70
Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin	69
Role and potential therapeutic use of antibodies against herpetic infections	69
Diverging effects of human recombinant anti-hepatitis C virus (HCV) antibody fragments derived from a single patient on the infectivity of a vesicular stomatitis Virus/HCV pseudotype	69
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines	68
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection	68
Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site on gp120SITE ON GP120	66
Modulation of epitope-specific anti-hepatitis C virus E2 (Anti-HCV/E2) antibodies by anti-viral treatment	65
Perspectives for the utilization of neutralizing human monoclonal antibodies as anti-HCV drugs	64
Interferon β-1a (IFNβ-1a) in COVID-19 patients (INTERCOP): study protocol for a randomized controlled trial	62
Nanosphere's Verigene (R) System to detect Multidrug-Resistant Gram-negative Bacterial Outbreak: a prospective study in 60 patients	61
Molecular dissection of the IGM/K antibody repertoire in an HCV-infected patient with cryoglobulinemia	59
Molecular dissection of the human humoral response against HCV E2 glycoprotein by cloning of the antibody repertoire in phage display combinatorial vectors	59
Human Monoclonal Antibody able to nneutralize a broad range of H1 and H3 subtype influenza A viruses	59
Longitudinal microbiome profile associates with the risk of major transplant-related complications in allogeneic HSCT recipients	58
Rapid Molecular Detection of Pathogens in 516 Consecutive Haematological Patients with Febrile Neutropenia	58
Photo quiz: Neurological symptoms in a 74-year-old diabetic woman admitted to the emergency room	58
Microbiological Diagnosis of Sepsis: The Confounding Effects of a “Gold Standard”	58
Facing the Rising Tide of Multidrug Resistant Gram-Negative Pathogens in Allogeneic HSCT with Nanosphere's Verigene((R)) System	57
Molecular Cloning of a Human Monoclonal Antibody neutralizing a broad range of H1 subtype influenza virus including swine-origin influenza virus (S-OIV)	55
Oral and Fecal Microbiota in Lynch Syndrome	53
Rational dosing strategies of colistin: what about resistance?	49
Evaluation of a synergistic interactions of anti-E2/HCV monoclonal antibodies	49
Improving the Diagnostic Algorithm for Sepsis: Adjuvant Role of SeptiFast in 491 Consecutive Hematological Patients	49
RAPID MOLECULAR DETECTION OF PATHOGENS IN 1941 BLOOD SAMPLES FROM 516 CONSECUTIVE PATIENTS WITH FEBRILE NEUTROPENIA	49
Multiplex PCR-based assay (SeptiFast) for rapid detection of pathogens in febrile neutropenia: results in 273 consecutive patients	48
Definition of biological activity and quantitation of different families of human anti-HCV/E2 antibodies by generation of human recombinant anti-E2 monoclonal Fab by phage display combinatorial repertoire library	47
Molecular Diagnosis of Scedosporium apiospermum Keratitis	45
Totale	7.066

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	38.178
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	38.178

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2022/2023	232	0	0	0	0	0	0	0	0	123	71	20	18
2023/2024	1.288	163	195	164	256	300	87	7	25	35	35	9	12
2024/2025	1.248	9	38	262	62	46	68	55	57	155	75	92	329
2025/2026	3.157	288	168	156	390	203	125	717	157	433	205	165	150
2026/2027	1.141	54	152	301	370	264	0	0	0	0	0	0	0
Totale													7.066